Finaloop Raises $35 Million in Series A Funding to Revolutionize Ecommerce Accounting with AI Finaloop, an AI-driven accounting platform catering to ecommerce, has secured $35 million in its Series A funding round, setting its sights on transforming financial management for online businesses. The round was led by Lightspeed Venture Partners, with participation from new investors…
Ubie, founded in 2017, has announced it has now secured over $125 million in cumulative funding, as it accelerates its expansion into the U.S. with generative AI and provider-focused solutions. The milestone builds upon the company’s previous $26.2M Series C, bringing total backing to more than $59.8M since the previous raise in August 2022. Led…
Knack, a student‑success platform that enables higher‑education institutions to manage and expand peer‑learning programs, has closed a Series B round led by New Markets Venture Partners (NMVP), and simultaneously appointed Megan Dusenbery as Chief Executive Officer, while founder Samyr Qureshi transitions to Executive Chairman of the Board. Founded in 2015, Knack has partnered with major institutions—such as Fordham University, Northeastern University, the University of Florida…
Marble, a pioneering startup founded by former Headway leaders, is set to reshape adolescent mental health care with its innovative approach to group therapy. Founded by Jake Sussman and Dan Ross, both former co-founders at Headway, Marble aims to address the alarming rise in depression, anxiety, and suicide rates among U.S. teens by offering accessible…
In a significant move bolstering its commitment to advancing science-driven solutions, Freeflow Ventures has announced the successful raise of $90 million in funding. This includes $50 million from its Fund Two and Opportunity Fund, complementing its existing $25 million Fund One and Special Purpose Vehicles (SPVs). Amidst a challenging venture capital landscape, Freeflow’s doubled fundraising…
Rejuvenate Bio, a pioneering biotechnology firm specializing in gene therapies, announced today the reception of a $4 million grant from the California Institute for Regenerative Medicine (CIRM) to propel the development of its innovative gene therapy, RJB-0402, aimed at treating desmoplakin gene variant arrhythmogenic cardiomyopathy (DSP ACM). Desmoplakin gene variant arrhythmogenic cardiomyopathy (DSP ACM) is…
As geopolitical tensions reshape the global minerals landscape, St George Mining is making a decisive play. The Australia-listed explorer has secured a hefty A$72.5 million in fresh funding to fast-track development of its Araxá rare earths and niobium project in Brazil—at a moment when the West is scrambling to loosen China’s grip on critical mineral…
In a strategic move to meet the burgeoning demand for locally grown, pesticide-free greens, GrowUp, the UK’s leading vertical farming enterprise, has secured a substantial £38 million investment from Generate Capital. This funding is poised to propel GrowUp’s expansion efforts and solidify its position as a trailblazer in sustainable agriculture within the UK. Generate Capital’s…
In a significant milestone for antibiotic innovation, Blacksmith Medicines has been granted both Qualified Infectious Disease Product (QIDP) and Fast Track designations by the U.S. Food and Drug Administration (FDA) for its novel antibiotic candidate, FG-2101. This small molecule inhibitor targets LpxC, a metalloenzyme essential to the survival of Gram-negative bacteria, including multidrug-resistant strains—an area…
In a strategic maneuver set to redefine the corporate travel sector, TravelPerk has announced its acquisition of Chicago-based AmTrav alongside a substantial $135 million funding boost. This move not only underscores TravelPerk’s commitment to expanding its footprint in the lucrative U.S. market but also positions it as a formidable player in global travel technology. Founded…
